Ventas stock
Price history
+11.21% over the period1 year: from $79.00 (November 17, 2025) to $87.86 (November 17, 2026), +11.21%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 17, 2026 | $87.86 |
| October 30, 2026 | $84.80 |
| September 30, 2026 | $85.02 |
| August 31, 2026 | $91.17 |
| July 31, 2026 | $93.51 |
| June 30, 2026 | $88.80 |
| May 29, 2026 | $84.42 |
| April 30, 2026 | $87.86 |
| March 31, 2026 | $81.78 |
| February 27, 2026 | $86.16 |
| January 30, 2026 | $77.67 |
| December 31, 2025 | $77.38 |
| November 28, 2025 | $80.63 |
| November 17, 2025 | $79.00 |
At a glance
The company
S&P 500 real estate company operating approximately 1,450 senior housing and healthcare properties across North America and the United Kingdom
Latest results
Quarter to September 30, 2026 · EPS $0.13 (estimate $0.16)
TickerLandia's take on Ventas
- Pricier than usual relative to earnings: P/E on the latest fiscal year 163 vs a median of 46 over its last 6 fiscal years.
- Pricier than similar companies: trailing 12-month P/E 171 vs 36 (+369%) in a group of 11.
- Strong point: Growth (67/100 in its group). Weak point: Profitability (20/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−13.35% from the 52-week high
Analysts · 23 analysts
Average target$99.45+12.97% vs. price
Buy 18 · Hold 5 · Sell 0 · Buy
TickerLandia Fingerprint: Ventas
Compared with similar companies: very high price and very low risk.
Financials and price compared with 175 companies in related industries (real_estate), worldwide. Momentum and risk compared with 883 North American stocks.
Pricevery high85
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 170.9 98 Price/sales 6.97 63 EV/EBITDA 24.3 81 Price/book 2.97 88 Forward P/E 127.9 97 Profitabilitylow20
How much it earns on revenue and capital.
Metric Value Position in group Gross margin 39.3% 22 Net margin 3.9% 15 ROE 1.9% 17 ROA 2.1% 32 Operating margin 14.6% 15 Earnings stabilityaverage52
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 0.9% 91 Loss-making yearscounts in reverse: lower means more earnings stability 2 of 5 annual reports 14 Growthhigh67
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +12.21% 71 Revenue growth (year over year) +21.50% 84 Earnings growth (year over year) −9.10% 46 Financial strengthlow35
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Interest coverage 1.53 10 Debt/equitycounts in reverse: lower means more financial strength 0.77 47 Current ratio 0.37 24 Net debt/EBITDAcounts in reverse: lower means more financial strength 5.64 59 Dividendhigh65
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years 28 years 84 Dividend yield 2.3% 16 Payout ratiopays out more than its earnings 392.3% 94 Market momentumaverage48
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) +0.84% 51 Relative strength (6 months) +0.56% 45 1-year return +11.44% 49 Distance from 200-day average +0.91% 50 Riskvery low17
How much the price swings.
Metric Value Position in group Volatility (60 days) 22.4% 17 Beta (1 year) −0.17 7 Maximum drawdown (12 months) 20.4% 28
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 18, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Ventas is pricier than in the past and pricier than similar companies
On the latest fiscal year's earnings (2025), Ventas's P/E today is 162.7, above the median of its last 6 fiscal years (45.6; between 15.9 and 143.3 from 2016 to 2025). Ventas's P/E (trailing 12 months): 170.9, +369% against the median of a group of 11 similar companies (36.5).
Compared with 11 similar companies
| Metric | Ventas | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 170.9 | High | |
| Forward P/E | 127.9 | High | |
| ROE | 1.9% | Low | |
| Price/book | 2.97 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Ventas. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$1.83B
Latest quarter · Q3 2026
Net income
$65.38M
Latest quarter · Q3 2026
Quarterly net margin
3.6%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- $47B
- P/E
- 170.9
- EPS
- $0.52
- Volume
- 2.99M
- Daily trading
- €274.93M
- Dividend yield
- 2.32%
- Last ex-dividend on September 30, 2026
How Ventas is changing
All resultsRevenue grew 9.0% a year on average over the last 5 years
Shares outstanding up 22.9% in 5 years
Revenue has grown for 5 fiscal years in a row
Returns
Ventas returns with dividends
$1,000 invested in Ventas 5 years ago, on November 17, 2021, would be worth $1,919 today with dividends reinvested: +91.91% in total, +13.93% per year. On price alone it would be $1,628 (+62.75%).
| Period | Ventas | S&P 500 | $1,000 becomes |
|---|---|---|---|
| 1 month | +3.96% | −3.17% | $1,040 |
| 6 months | +0.67% | +0.11% | $1,007 |
| Year to date | +13.54% | +8.34% | $1,135 |
| 1 year | +13.96% | +11.15% | $1,140 |
| 3 years | +115.51% | +64.30% | $2,155 |
| 5 years | +91.91% | +58.18% | $1,919 |
| 10 years | +123.67% | +239.10% | $2,237 |
Over the last 6 months it has done better than 47% of the stocks in the Finance sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment
The chart in detail
Ventas: technical analysis
Ventas shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 12.4% below its all-time closing high ($100.53, July 24, 2026).
- Trend
- No clear trend
- RSI (14 sessions)
- 53
- Between 30 and 70
- vs 200-session average
- +0.91%
Active signals
Death cross: the 50-session average has crossed below the 200-session average.
since November 5, 2026
Support and resistance
Price areas where Ventas has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance$94.55+7.39%2 touches, last on August 26, 2026
- Last price$88.04
- Support$87.70−0.39%5 touches, last on October 26, 2026
- Support$85.60−2.77%4 touches, last on June 11, 2026
- Support$80.38−8.70%4 touches, last on October 8, 2026
Volatility and risk
Over the last year it has often moved in the opposite direction to the S&P 500.
- Beta (1 year) vs S&P 500
- −0.17
- Volatility (60 sessions, annualised)
- 22.4%
- Largest fall in the last year
- −20.38%
Close of November 17, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Ventas: seasonality
Average monthly price change over 30 years
Over the last 30 years, the strongest month for Ventas has been July: +3.47% on average, positive in 21 years out of 30. The weakest has been March: −1.36% on average, positive in 15 years out of 29. November, the current month, has been positive in 16 years out of 29 (−0.27% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +1.50% | +0.26% | 16 of 29 |
| February | −0.02% | +0.63% | 16 of 29 |
| March | −1.36% | +0.83% | 15 of 29 |
| April | +2.75% | +3.00% | 19 of 29 |
| May | +2.50% | +1.09% | 18 of 29 |
| June | +0.16% | +1.06% | 16 of 30 |
| July | +3.47% | +4.64% | 21 of 30 |
| August | +0.33% | +0.62% | 15 of 30 |
| September | −0.18% | −0.86% | 14 of 30 |
| October | −1.03% | +0.96% | 16 of 30 |
| November | −0.27% | +0.74% | 16 of 29 |
| December | +2.74% | +1.56% | 20 of 29 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Ventas and its competitors
Senior housing communities are the part of Ventas, Inc. best known to the public, with more than 900 of them offering supported living to older residents. The portfolio totals about 1,450 properties, and the remaining holdings include medical buildings and research centers across Canada, the United States and the United Kingdom. Operational decisions draw on data from the Ventas OITM platform, combined with the company's operating experience and its long-standing relationships with partners.
- Headquarters
- Chicago, United States
- Employees
- 542
- Founded
- 1983
- Chief executive
- Debra Cafaro
| Company | Market cap | ROE | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| VentasVTR | $47B | 1.9% | 170.9 | +0.67% |
| Healthpeak PropertiesDOC | $14.51B | 4.4% | 37.0 | +0.52% |
| WelltowerWELL | $180.3B | 3.9% | 104.1 | +14.98% |
| Aedifica NV/SAAED | $6.11B | 12.2% | 6.63 | −3.40% |
| Care Property InvestCPINV | $590.89M | 9.4% | 8.10 | −0.78% |
| Vivmark ResidentialVMRK | $47.49B | 8.5% | 25.7 | +0.22% |
Same industry or related industries, similar size. Compare Ventas with its competitors · Full profile
